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Objectives: This study aimed to provide evidence on the therapeutic prescribing activity by community
optometrists in Scotland and to determine its impact onworkload in general practice and ophthalmology
clinics.
Study design: Scottish administrative healthcare data for a 53-month period (November 2013eApril
2018) were used to analyse non-medical prescribing practice by optometrists.
Methods: Using interrupted time-series regression (Autoregressive Integrated Moving Average), we
assessed the impact of optometrist prescribing on ophthalmology outpatient attendances and general
practice prescribing for eye disorders.
Results: A total of 54,246 items were prescribed by 205 optometrists over the study period. Since the
commencement of data recording, optometrist prescribing activity increased steadily from a baseline of
zero to 1.2% of all ophthalmic items prescribed. Neither the monthly number of items prescribed nor the
size of optometric workforce were associated with a reduction in ophthalmology outpatient appoint-
ments over time.
Conclusions: Optometrists increasingly contribute to community ophthalmic prescribing in Scotland,
releasing capacity and lessening general practice, but not secondary care workload. There appears to be
an underutilisation of optometrists related to the management of dry eye, which represents an oppor-
tunity to release further capacity.
© 2021 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Population growth, increasing life expectancy and a shift of
illness patterns from acute to long-term conditions and multi-
morbidity is increasing demand for health and eye care services
globally.1e4 Recent global estimates indicate that health systems
and eye care providers in particular will face significant challenges
related to an increasing prevalence of visual impairment, with the
number of blind people projected to be 38.5 million by 2020 and
115 million worldwide by 2050.3 In order to mitigate the antici-
pated rise in visual impairment, the WHO has developed a global
action plan for universal eye care5 that includes recommendationsiences, Glasgow Caledonian
d Kingdom. Tel.: þ44 (0) 141
scheit).
r Ltd on behalf of The Royal Socierelating to more closely integrated eye care services to ensure
comprehensive care.6 In the UK, a considerable rise in sight-
threatening conditions such as glaucoma (49%), cataract (52%)
and neovascular age-relatedmacular degeneration (64%) have been
predicted by the year 2035.7 Nonesight-threating conditions such
as dry eye are also common among the older populations.8 Short-
term initiatives such as waiting time reduction programmes are
unlikely to be sufficient to resolve long-term increases in demand.7
To respond to the increasing demand for eye care and improved
timeliness and patient access to medicines, some countries such as
the UK have developed strategies to shift certain types of clinical
care from hospital to community settings.9,10 This includes the
introduction of non-medical prescribers (NMPs) to healthcare
systems, where autonomous prescribing authority is delegated to
non-medical professionals such as nurses, pharmacists and op-
tometrists.11,12 Following a government-commissioned review of
prescribing,13 independent prescribing authority was extended to
UK optometrists in 2008, with the specialist prescriber registerty for Public Health. This is an open access article under the CC BY-NC-ND license
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that required care were managed by their general practice or in
secondary care, but the new framework allowed optometrists to
autonomously manage eye conditions in the community.14 In order
to qualify as optometrist independent prescriber (OIP), optome-
trists are required to have a minimum of two years clinical work
experience, to undertake three postgraduate modules in thera-
peutic prescribing, to complete 24 clinical hospital sessions under
the supervision of an ophthalmologist and to pass a common
computer-based assessment.15
Evidence fromother clinical areas suggests that NMPs in nursing
and pharmacy provide services that result in more timely and
efficient care.16,17 A recent Cochrane review suggested that NMPs
can deliver comparable patient outcomes such as in the clinical
management of hypertension, hypercholesterolaemia, diabetes and
medication adherence as well as improved patient satisfaction and
quality of life. No studies on optometrist NMP practice were iden-
tified as part of this review,18 but scope of practice patterns of NMP
by optometrists have been assessed in studies from Australia,19
Canada20 and New Zealand.21 While general practice faces an in-
crease in demand for primary care, leading to higher workloads
(overburden), NMP practice has the potential to address the burden
on stretched services, to increase overall capacity and efficiency of
community health care and to reduce primary care workload, as
has been shown for pharmacist NMPs.16
Evidence of the impact of NMPs related to other professions (e.g.
pharmacy) is becoming more readily available,22,23 but despite the
introduction of OIP a decade ago, there is considerable uncertainty
relating to the range of prescribing activity and the clinical and
economic impact of OIP practice.18 Given that both general prac-
tices and ophthalmology clinics in secondary care are experiencing
continuous increases in demand for eye care services, it would be
timely and beneficial to ascertain the impact of OIP practice. This
studywas designed to provide evidence on community OIP practice
in Scotland between 2013 and 2018, i.e. for a period unaffected by
the COVID-19 pandemic, and to determine its impact on i) general
practice eye careerelated workload and ii) ophthalmology outpa-
tient workload using Scottish administrative healthcare data.
Methods
Optometrist prescribing data
Anonymised data were provided by the Information Services
Division (ISD) of NHS National Services Scotland24 (now part of
Public Health Scotland) for the period of November 2013 to April
2018 on all items prescribed by optometrists holding an indepen-
dent prescriber qualification. Prescribing data were available by
month and by OIP practitioner working in NHS Health Boards in
Scotland.a Individual level data were aggregated to represent the
number of items reimbursed per health board and per calendar
month. Data from optometrists who were not qualified indepen-
dent prescribers were not included in this administrative dataset
and are therefore not available for analysis.
General practice prescribing data
General practice prescribing datawere obtained from ISD for the
period October 2015 to April 2018 for all general practices ina Data were not available for two health boards, NHS Orkney and NHS Shetland,
as there was no recorded non-medical OIP prescribing activity over the study
period. Data from one health board, NHS Western Isles, were excluded from the
analysis because of small numbers and to comply with data protection legislation.
108Scotland and were used to calculate the combined total of all OIP
and general practice prescribing for eye conditions. Owing to the
shorter time period for which general practice data were available,
comparison with OIP was made only for this period (October 2015
to April 2018).
Ophthalmology outpatient data
Data on routine monthly attendance at ophthalmology outpa-
tient clinics were obtained for all NHS Health Boards in Scotland
from ISD for the period of November 2013 to April 2018. Data were
reported as being 98%e99% complete.25 Information from NHS
Orkney, NHS Shetland and NHS Western Isles were excluded to
ensure comparability with OIP data.
Types of medicines analysed
The analysis focussed specifically on OIP and general practice
prescribing activity relevant to eye care and was limited to eye-
related medicines specified in section 11 of the British National
Formulary (BNF) and eye products listed in BNF (pseudo) section
21.26
Sub-group analysis and exclusion
We carried out a sub-group analysis to assess prescribing pat-
terns for ocular preparations of antibacterials, anti-inflammatories
and dry eye treatments. Prescriptions relating to items which were
clearly unrelated to ocular disease were excluded from the analysis
(0.6% of all items).
Statistical analysis
Descriptive statistics were generated for prescribing activity of
OIPs over time and by NHS Health Board area. OIP prescribing ac-
tivity was measured as the percentage of all eye-related prescribing
(total number of items prescribed by OIP and general practice).
Attendance rates at ophthalmology outpatient clinics are presented
per 100,000 population.
We used interrupted time-series regressionwith Autoregressive
Integrated Moving Average (ARIMA) errors to assess the impact of
two independent variables: i) the number of items prescribed by
OIPs and ii) the number of active OIP practitioners on the number of
patients seen at ophthalmology outpatient clinics in NHS Scotland
over a 53-month period. The analytic strategy consisted of initially
modelling the ophthalmology outpatient clinic attendance data
time-series to obtain an adequate preliminary model and then
testing the effect of the two independent variables. Several models
were developed, and the most parsimonious model was selected
using the Akaike Information Criterion. The effect of OIP prescribing
activity (number of items prescribed per month) and the number of
active OIPs at each month were tested separately using the best
fitting model. The analysis was carried out using the Stata SE v15
software package (Stata Corp, College Station, TX).
Ethics statement
As data were non-identifiable administrative prescribing data,
ethical approval was not required.
Patient and public involvement
The data used were national administrative healthcare data, and
patients were not involved in this study.
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Regional distribution of OIPs
A total of 205 OIP practitioners were prescribing in Scotland
during the study period. Fig. 1 shows the number of OIP practi-
tioners, calculated per 100,000 population for each local health
board. The number of practitioners increased year-on-year,
particularly in larger health boards such as NHS Ayrshire and
Arran, NHS Grampian and NHS Greater Glasgow and Clyde (Fig. 1).
Quantity of prescribed items, temporal and regional variability
Over the 53-month period, a total of 54,246 items were pre-
scribed by OIPs. A consistent trend of increasing prescribing activity
with some seasonal dips was observed (Fig. 2).
Fig. S1 A and S1 B (supplementary files) contrast the trends in
the number of prescribed items over time between an urban setting
(NHS Greater Glasgow and Clyde) and a rural setting (NHS High-
land). The annual prescribed items and the relative differences for
all full calendar years are shown by health board (Supplementary
Tables 1 and 2, respectively). Overall, prescribing activity
increased across Scotland for each full year reported. Looking at the
most recent year-to-year differences (2016e2017), there was a
relative increase in items prescribed, ranging from þ7% in NHS Fife
to þ160% in NHS Borders. A reduction in prescribing activity was
observed for a single health board (NHS Forth Valley: 79%).
Comparison of OIP and general practice prescribing for eye disorders
Using the latest monthly data available (April 2018), the 205
OIPs issued approximately 1.2% of all eye-related prescriptions is-
sued by OIPs and general practices combined, with general practice
prescriptions originating from 1072 practices. Both the magnitude
and the proportion of prescribing carried out by OIPs wereFig. 1. OIP workforce numbers per 100,000 population by NHS Hea
109relatively low when compared to the volume of prescribing in
general practice. However, we observed a steady increase in OIP
prescriptions from a baseline of zero, alongside a corresponding
decrease in ophthalmic items prescribed in general practice. Be-
tween October 2015 and April 2018, OIPs represented approxi-
mately 3% of the combined number of general practice and OIP
prescribers in Scotland and prescribed 1.2% of all antibacterial
items, 2.4% of all anti-inflammatory items and 0.4% of dry eye items.
To illustrate the trend in OIP prescribing activity over time, the left-
hand side panel of Fig. 3 shows the number of items prescribed by
OIPs across Scotland. Timelines are presented in Fig. 3 for anti-
bacterials (Fig. 3A), anti-inflammatories (Fig. 3B) and dry eye
treatments (Fig. 3C), indicating an increase in OIP prescribing ac-
tivity. In contrast, a modest, albeit variable, reduction in the num-
ber of items prescribed in general practice for the same groups of
items is observed in the right-hand side panel of Fig. 3AeC.Impact of OIP practice on ophthalmology outpatient clinics: ARIMA
time-series analysis
Fig. 4 shows attendance rates at outpatient ophthalmology
clinics from November 2013 to April 2018 for each NHS Health
Board. The figure serves two purposes. It allows for i) a time-related
comparison of normalised outpatient appointments and ii) an
appraisal of regional outpatient activity. Comparing year-on-year
patterns, we observed a variable pattern of outpatient activity
across Scotland, with a steady decrease of outpatient attendances
in some areas (e.g. NHS Grampian, NHS Borders and NHS Lanark-
shire). The focus of this analysis is on the five full calendar years of
data (2013e2017; indicated by 2013-navy; 2014-burgundy; 2015-
green; 2016-orange; 2017-mint). Data for 2018 (red) represent
incomplete data because of lack of data availability but are shown
to allow for the normalised regional comparisons between health
board areas per 100,000 population. This comparison is still valid as
the cutoff point was identical across all health board areas.lth Board over time. OIP, optometrist independent prescriber.
Fig. 2. Monthly items prescribed by OIP practitioners, Scotland, 2014e18. OIP, optometrist independent prescriber.
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land. The final fitted model was an ARIMA with one regular
autoregressive term and first order differencing, with 53 obser-
vations (months). The analysis for the association of ophthal-
mology outpatient appointments and the number of items
prescribed by OIPs per month found a small but clinically irrel-
evant increase in ophthalmology outpatient appointments over
time (0.08%; confidence interval [CI], 0.03%e0.14%; P ¼ 0.004;
Table 1). Similarly, the size of the OIP workforce was not associ-
ated with a reduction in ophthalmology outpatient appointments,
with both the point estimate of the effect size and bounds of the
CI excluding a negative association (1.0%; 95% CI, 0.34e1.86%;
P ¼ 0.004). With the slight 1.0% increase in outpatient atten-
dances, it is, at present, not likely that OIP practice is causally
related to any change in hospital workload. However, analyses by
Optometry Scotland show that the increase in hospital appoint-
ments has increased at a lower rate in Scotland than in England
(unpublished data), and OIP practice may have contributed to this
lower rate of increase.Discussion
Main findings of the study
This study provides, for the first time, a quantitative time-
series analysis of optometrist prescribing in Scotland in rela-
tion to general practice and outpatient activity using NHS
administrative data. Non-medical prescribing capacity in Scot-
tish community eye care has increased steadily since data
recording began in 2013 and continues to develop. Our findings
suggest positive effects of OIP practice, e.g. optometrists
contributing to lessening the burden in primary care, and a
modest reduction in general practice prescribing for eye disor-
ders. This observation suggests a release of capacity and110therefore a positive impact on workload in general practice. The
outcomes of our study suggest that, rather than contributing to a
shift of eye care from secondary to primary care, there is a
(slow) shift occurring within primary care, i.e. from general
medical practice to optometric practice. Given the demand and
workload challenges in general practice, such a shift is desirable
and has the potential to release additional general practice ca-
pacity in the long term.What is already known on the topic
OIP has been introduced in a number of countries, including
Australia, Canada, New Zealand and the USA.19e21,27 In Australia, a
scope of practice survey indicated that just under half of respond-
ing optometrists were licensed to prescribe medicines in the
community. The most commonly prescribed groups of drugs
included dry eye treatment, decongestants and antiallergic medi-
cations, but there were low rates of prescriptions for anti-in-
fectives.19 Since 2011, community optometrists in Ontario, Canada,
have been managing patients before referral to hospital eye ser-
vices, with 6% of referred patients being on a prescription medi-
cation issued by optometrists. As in the UK, there are few
restrictions regarding the clinical circumstances under which op-
tometrists are allowed to prescribe for ocular disorders.20 In New
Zealand, which is comparable to Scotland in geographic diversity,
population figures and the publicly funded healthcare system, non-
medical prescribing has also been implemented. Most optometrists
in New Zealand practice in the community, but an overarching NMP
policy that allows for safe and sustainable delivery of NMP services
was recently still to be developed (2017).21 In the UK, OIP training
takes place at the postgraduate level, whereas optometrists in New
Zealand gain prescribing authority as part of their undergraduate
training/prequalification training, and 66% of all optometrists are
optometrist prescribers.21
Fig. 3. A. Antibacterial ophthalmic prescribing (number of items) by OIPs (left) vs general practice (right). B. Anti-inflammatory ophthalmic prescribing by OIPs (left) vs general
practice (right). C. Prescribing for dry eye and tear deficiency by OIPs (left) vs general practice (right). GP, general practice; OIP, optometrist independent prescriber.
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transfer of care
One group of ophthalmic items commonly prescribed in general
practice were dry eye related. While the overall proportion of items
prescribed by optometrists is gradually increasing, there appears to
be underutilisation of community optometrists in the management
of dry eye. Even though a proportion of patients with dry eye will
obtain lubricants classified for pharmacy sales without the need for
a prescription, a further reduction in dry eyeerelated workload in
general practice would release additional capacity and could be
achieved by transferring the care of patients with dry eye to com-
munity optometry. Optometrists are well placed to manage these
patients, allowing general practices to dedicate consultation time to
patients with more severe conditions. However, many patients will
be attending general practice for non-ocular morbidity and
mention dry eye as one of several concerns, thus allowing general
practitioners (GPs) to prescribe dry eye treatments alongside any
systemic medication that may be required.111A transfer of care within primary care is already under way,
partly facilitated by the new (2006) ophthalmic contract in
Scotland28,29 and partly through locally organised enhanced eye
care schemes in which accredited optometrists may prescribe/
supply without being qualified NMPs. Notwithstanding, a larger
scale transfer of care would require careful impact analysis,
which is beyond the scope of the present article. Factors that
would need to be considered include economic aspects and
viability for general practice, patient access and structural factors
such as the capacity of OIPs to issue repeat prescriptions. How-
ever, if primary care, optometry, commissioners and policy-
makers agree that such change continues to be desirable, the
patient-centred service and pathway changes will require time to
reach maturity.
In contrast to the observed effect of OIP on general practice,
we did not find robust evidence that the number of items pre-
scribed or the number of active OIP practitioners had a measur-
able effect on the number of ophthalmology outpatient
Fig. 4. Attendance rate at outpatient ophthalmology clinics per 100,000 population by NHS Board.
Table 1
Outcome of ARIMA model for two independent variables: i) number of items prescribed and ii) number of OIPs. Akaike Information Criterion
ARIMA model Estimated effect (%) 95% CI P value AIC Adjusted R2
Number of prescribed items 0.08 0.03 to 0.14 0.004 44.54 0.67
Number of OIPs 1.00 0.34 to 1.86 0.004 38.29 0.64
AIC, Akaike Information Criterion; CI, confidence interval; OIP, optometrist independent prescriber.
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optometrists become more involved in the management of pa-
tients with potentially sight-threatening ocular disease such as
glaucoma.
Aspects related to demand for OIP in the UK
As in general practice, increasing demand on ophthalmology
outpatient services suggests that changes in the organisation of
care are required. The introduction of NMP for optometrists reflects
not only a response to the need for a change to eye care service
delivery but also the need to respond to demographic and work-
force changes such as longer life expectancy and the fact that
substantial proportions of healthcare workers, including GPs and
ophthalmologists, are reaching retirement age. At hospitals across
the UK, ophthalmology services accounted for nearly 10% of all
secondary care outpatient appointments and for approximately 6%
of surgical procedures.30
This study suggests that OIP practice has positive effects in that
it can release capacity in primary care ophthalmic prescribing.
However, even though there has been a consistent increase in ac-
tivity, themagnitude of OIP practice is still comparatively lowwhen
viewed against the volume of general practice ophthalmic pre-
scribing. For this reason, the time-series analysis for the effect of
OIP prescribing on general practice prescribing should be repeated
in five years’ time, when the OIP activity has matured further and
prescription rates have increased. Equally, analyses relating to the112quality and formulary adherence of OIP practice are needed to
ascertain the quality of OIP services.
In the future, further insight into OIP activity and its impact
could be gained by validating centralised prescribing data using
regional or localised prescribing audits or research studies. Ideally,
such smaller scale studies would also consider longitudinal aspects
such as OIP workforce trends and the demand for OIP practice.
Study limitations
Our study was limited by the availability of general practice
prescribing data (2015 onwards). A further limitation was the un-
availability of diagnostic patient-level data, which prevented us
from ascertaining with confidence whether disease-specific pre-
scribing recommendations were followed. ARIMA modelling was
also attempted using general practice prescribing as the dependent
variable. However, the magnitude of OIP prescribing was too small
relative to that of general practice prescribing.
Conclusions
OIP practice is making a steadily increasing contribution to eye-
related prescribing in Scotland, potentially reducing workload of
general practices. Greater utilisation of OIPs for the management of
some ocular conditions has the potential to further alleviate de-
mand on general practice. There is limited evidence of an
S. Jonuscheit, C. Geue, R. Laidlaw et al. Public Health 196 (2021) 107e113association between OIP practice and hospital outpatient activity.
However, this is not unexpected, as subject experts and policy-
makers have confirmed. In order to assess the quality of OIP prac-
tice, patient-level information should be included in prescribing
data sets, and the economic impact of OIP practice, which is
currently unknown, should be carefully assessed.Author statements
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